BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Policy

  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Metabolix, Inc.

  February 21, 2012

   · 

  1 min read
• FDA

  ReCor Medical Announces CE Mark Approval for Its Novel PARADISE™ Ultrasound Transcatheter Renal Denervation System

  February 21, 2012

   · 

  1 min read
• Business

  Aptiv Solutions Announces Key Appointments to Strengthen its Focus on Adaptive Clinical Trial Execution

  February 21, 2012

   · 

  1 min read
• Pharm Country

  Acorda Therapeutics to Present at Citi 2012 Global Health Care Conference

  February 21, 2012

   · 

  1 min read
• Biotech Bay

  Aradigm Corporation Release: US Patent Protection for Pulmaquin™ its Extended with Issuance of a Composition of Matter Patent

  February 21, 2012

   · 

  1 min read
• Business

  Repligen Corporation Reports Preliminary Financial Results for the Quarter and Nine-Month Fiscal Period Ended December 31, 2011

  February 21, 2012

   · 

  1 min read
• FDA

  FDA Clears Applied Spectral Imaging (ASI)'s GenASIs Advanced Imaging for HER-2/neu Analysis

  February 21, 2012

   · 

  2 min read
• Drug Development

  BioLineRx Ltd. Announces Publication of Pre-Clinical Results Demonstrating Efficacy of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity

  February 21, 2012

   · 

  1 min read
• Genetown

  Covidien to Present at Upcoming Investor Conferences

  February 21, 2012

   · 

  1 min read
• Policy

  Repligen Corporation Announces FDA Grant of Priority Review for SecreFlo™ NDA

  February 21, 2012

   · 

  1 min read